Kineta

Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda
BioSpace
Mon, 10/17/22 - 10:51 am
Kineta
Merck
Keytruda
anti-VISTA
monoclonal antibodies
solid tumors
Yumanity's end: J&J pays $26M for neuroscience assets as reverse merger erases biotech
Fierce Biotech
Mon, 06/6/22 - 10:29 am
Yumanity Therapeutics
JNJ
Kineta
Merck
M&A
Kineta Gets $15M in New Cancer Drug Partnership with Pfizer
Xconomy
Mon, 12/17/18 - 11:27 pm
Pfizer
Kineta
drug development